tiprankstipranks
Trending News
More News >
Cantargia AB (SE:CANTA)
:CANTA

Cantargia AB (CANTA) Similar Stocks

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cantargia AB
kr4.10
kr1.02B
8.08
138.91%
1 Buy
0 Hold
0 Sell
Moderate Buy
Oncopeptides AB
kr4.57
kr1.18B
-3.97
226.43%
SynAct Pharma AB
€2.12
€117.42M
-10.85
175.32%
Xbrane Biopharma AB
€1.26
€28.18M
0.04
-70.14%
0 Buy
0 Hold
0 Sell
Hold
Guard Therapeutics International AB
€0.04
€2.61M
-0.05
-97.47%
Immunicum AB
€0.48
€29.22M
-2.62
-35.14%
0 Buy
0 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SE:CANTA
Cantargia AB
4.10
2.38
138.91%
SE:ONCO
Oncopeptides AB
4.57
3.17
226.43%
DE:8F8
SynAct Pharma AB
2.12
1.34
171.79%
DE:7XB
Xbrane Biopharma AB
0.88
-1.20
-57.69%
DE:5LH0
Guard Therapeutics International AB
0.04
-1.59
-97.55%
DE:1YG0
Immunicum AB
0.48
-0.26
-35.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts